Table 3.
Risk factor for case-fatality: logistic regression analysis
| Factor | n | % | Unadjusted OR(95% CI) |
Adjusted OR(95% CI) |
|
|---|---|---|---|---|---|
| Age(year) | < 40 | 113 | 44.3 | 1.00 | 1.00 |
| ≥ 40 | 43 | 46.7 | 1.10(0.684-1.779) | 1.033(0.529-2.018) | |
| Sex | Male | 77 | 43.8 | 1.00 | 1.00 |
| female | 79 | 46.2 | 1.10(0.723-1.686) | 1.033(0.566-1.887) | |
| Address | Addis Ababa | 133 | 50.8 | 1.00 | 1.00 |
| Outside Addis Ababa | 23 | 27.1 | 0.360(0.210-0.615) | 0.282(0.127-0.630) | |
| History of ART treatment |
Yes | 21 | 38.9 | 1.00 | 1.00 |
| No | 135 | 46.1 | 1.343(0.742-2.430) | 1.1(0.506-2.393) | |
| Cotrimoxazole (prophylaxis) |
Yes | 8 | 53.3 | 1.00 | 1.00 |
| No | 148 | 44.6 | 0.704(0.249-1.986) | 0.992(0.266-3.705) | |
| Altered sensorium | Yes | 99 | 52.9 | 1.00 | 1.00 |
| No | 57 | 35.6 | 0.492(0.319-0.758) | 0.514(0.288-0.916) | |
| Seizure | Yes | 65 | 54.6 | 1.00 | 1.00 |
| No | 91 | 39.9 | 0.552(0.353-0.863) | 0.519(0.288-0.935) | |
| Clinical stage of HIV infection | Stage iii | 3 | 20 | 1.00 | 1.00 |
| Stage iv | 153 | 46.1 | 3.419(0.947-12.339) | 2.069(0.370-11.562) | |
| CD4 count(/mm3) | < 200 | 85 | 42.3 | 1.00 | 1.00 |
| ≥ 200 | 6 | 26.1 | 0.482(0.182-1.273) | 0.572(0.205-1.595) | |
ART antiretroviral treatment, HIV human immunodeficiency virus CD4 cluster of differentiation 4